title: Risks and benefits of phase 1 oncology trials, revisited.
authors.forename: Razelle
authors.initials: R
authors.lastname: Kurzrock
authors.forename: Robert S
authors.initials: RS
authors.lastname: Benjamin
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D017321:Clinical Trials, Phase I as Topic / Q000941:ethics; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D018570:Risk Assessment
chemical_list: D000970:Antineoplastic Agents